A Study to Evaluate the Safety and Efficacy of ALMB-0168 in Patients With Osteosarcoma
Status:
Not yet recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
This is a phase I / II, multi-center, single-arm, open-label study to evaluate the safety and
efficacy of ALMB-0168 in patients with osteosarcoma whose prior standard treatment have
failed.